Reblozel Trademark Details

Reblozel was registered on Tuesday, March 29, 2016 and is currently owned by Celgene Corporation under the registration number 4926489 . This mark is alive with a status of Registered. The last case file activity for this mark occured 8 years ago on Tuesday, March 29, 2016, according to the United State Patent & Trademark Office
Word Mark Reblozel
Status Alive Registered 700 — Registered

Current Owner

Celgene Corporation of Summit, NJ

View all trademarks for Celgene Corporation
Other Trademarks for Celgene Corporation
Serial Number 86690852
Registration Number 4926489
Status Date Tuesday, March 29, 2016
Filing Date Tuesday, March 29, 2016
Registration Date Tuesday, March 29, 2016
Attorney Camille M. Miller

Correspondent

CAMILLE M. MILLER
Cozen O'Connor
1650 Market St
Philadelphia, PA 19103-7301

Case File Statements

Goods & Services Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, July 16, 2015
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.